Clara R Yook, M.D Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 385 Tremont Ave, East Orange, NJ 07018 Phone: 973-676-1000 Fax: 973-395-7126 |
Dr. Clara Naidine Finch Cruz, M.D. Pathology - Hematology Medicare: Medicare Enrolled Practice Location: 385 Tremont Ave, Dept. Pathology And Laboratory Medicine, East Orange, NJ 07018 Phone: 973-676-1000 Fax: 973-395-7126 |
Dr. Edward S Liu, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-395-4060 |
Dr. Suresh Kumar Gupta, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-266-4444 Fax: 973-266-2932 |
Jin K Choe, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 385 Tremont Ave, East Orange, NJ 07018 Phone: 973-676-1000 Fax: 973-395-7126 |
News Archive
SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.
Equal subsidies "surprisingly powerful," in promoting use of gold-standard medications, new study shows.
In a new pilot study, autistic adults showed real-life, functional improvement after a combination treatment approach that included graded exposure to fear and anxiety-producing experiences in a virtual reality environment.
The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of Radiology.
Cancer patients treated with the chemotherapy agent bevacizumab may be at an increased risk of treatment-related death when the drug is used in combination with other therapies.
› Verified 3 days ago